NCT05116956

Brief Summary

Necrotizing soft-tissue infections (NSTI) are rare and life-threatening bacterial infections characterized by subcutaneous tissue, fascia or muscle necrosis. Few prospective studies have been performed and our current knowledge on NSTI is mostly derived from retrospective single center studies. The "SKin and soft tissue necrotizing INfections in the ICU" (SKIN-ICU) study is a multinational prospective non-interventional cohort study that will include patients admitted to the ICU/intermediate care unit for NSTI or not. The objectives of the study are :

  1. 1.To assess hospital (i.e., ICU and hospital mortality) and medium-term (day-90 mortality, functional outcomes and health-related quality of life scores, HR-QoL) outcomes
  2. 2.To report the clinical presentation and microbiological epidemiology of NSTI and identify independent prognostic factors of mortality and altered quality of life

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,033

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2021

Completed
24 days until next milestone

Study Start

First participant enrolled

November 8, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 11, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 22, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 22, 2023

Completed
Last Updated

November 23, 2021

Status Verified

November 1, 2021

Enrollment Period

1.7 years

First QC Date

October 15, 2021

Last Update Submit

November 22, 2021

Conditions

Keywords

necrotizing soft tissue infectionNecrotizing FasciitisFournier Gangrene

Outcome Measures

Primary Outcomes (1)

  • mortality

    day 90

Secondary Outcomes (9)

  • Functional outcome

    day 90

  • Health-related quality of life outcome

    day 90

  • Microbiology

    During the first 72 hours of hospital admission

  • Skin grafting and amputation

    At day 90

  • SAPS II score

    Within 24 hours of hospital admission

  • +4 more secondary outcomes

Interventions

Multinational prospective, standard care data collection, non-interventional, study not involving human subjects

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patient with surgically-confirmed NSTI

You may qualify if:

  • Age \> 18 years
  • Patient with surgically-confirmed NSTI (i.e., macroscopic appearance of tissue during surgery revealing swollen, dull gray tissues with a thin, brownish exudate with or without necrosis)

You may not qualify if:

  • Patient deprived of liberty by judicial or administrative decision or patient under guardianship
  • Expressed opposition to project's participation at the project

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Henri Mondor

Créteil, 94000, France

RECRUITING

Related Publications (5)

  • Stevens DL, Bryant AE. Necrotizing Soft-Tissue Infections. N Engl J Med. 2017 Dec 7;377(23):2253-2265. doi: 10.1056/NEJMra1600673. No abstract available.

    PMID: 29211672BACKGROUND
  • Urbina T, Canoui-Poitrine F, Hua C, Layese R, Alves A, Ouedraogo R, Bosc R, Sbidian E, Chosidow O, Dessap AM, de Prost N; Henri Mondor Hospital Necrotizing Fasciitis Group. Long-term quality of life in necrotizing soft-tissue infection survivors: a monocentric prospective cohort study. Ann Intensive Care. 2021 Jul 2;11(1):102. doi: 10.1186/s13613-021-00891-9.

    PMID: 34213694BACKGROUND
  • Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014 Jul 15;59(2):147-59. doi: 10.1093/cid/ciu296. Epub 2014 Jun 18.

    PMID: 24947530BACKGROUND
  • Peetermans M, de Prost N, Eckmann C, Norrby-Teglund A, Skrede S, De Waele JJ. Necrotizing skin and soft-tissue infections in the intensive care unit. Clin Microbiol Infect. 2020 Jan;26(1):8-17. doi: 10.1016/j.cmi.2019.06.031. Epub 2019 Jul 5.

    PMID: 31284035BACKGROUND
  • Madsen MB, Skrede S, Bruun T, Arnell P, Rosen A, Nekludov M, Karlsson Y, Bergey F, Saccenti E, Martins Dos Santos VAP, Perner A, Norrby-Teglund A, Hyldegaard O. Necrotizing soft tissue infections - a multicentre, prospective observational study (INFECT): protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2018 Feb;62(2):272-279. doi: 10.1111/aas.13024. Epub 2017 Oct 29.

    PMID: 29082520BACKGROUND

MeSH Terms

Conditions

Fasciitis, NecrotizingFournier Gangrene

Condition Hierarchy (Ancestors)

FasciitisMusculoskeletal DiseasesBacterial InfectionsBacterial Infections and MycosesInfectionsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Nicolas de Prost, MD, PhD

    Service MIR, Hôpital Henri Mondor

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nicolas de Prost, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Nicolas de Prost

Study Record Dates

First Submitted

October 15, 2021

First Posted

November 11, 2021

Study Start

November 8, 2021

Primary Completion

July 22, 2023

Study Completion

July 22, 2023

Last Updated

November 23, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations